Skip to content

Clinical trials

Phase 1/2 Leukemia, Myeloid, Acute trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1/2 Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20132
20141
20162
20181
20191
20205
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Recruiting4
Completed3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene1
Constellation Pharmaceuticals1
Daiichi Sankyo1
Ellipses Pharma1
European Organisation for Research and Treatment of Cancer - EORTC1
Gamida Cell ltd1
Genmab1
Glycostem Therapeutics BV1
Hoffmann-La Roche1
Incyte Biosciences International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute18
Leukemia6
Myelodysplastic Syndromes5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Recurrence4
Hematologic Neoplasms3
Neoplasms2
Primary Myelofibrosis2
Blast Crisis1
Bone Marrow Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.